BioSpace News Archive

Regeneron Pharmaceuticals, Inc. and Society for Science announced that Yunseo Choi, 18, of Exeter, New Hampshire, won the $250,000 top award in the 2021 Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors.

Microba Life Sciences has appointed international executive, Mark Capone, as a Non-Executive Director of the Board, bringing with him more than 35 years of experience in the life sciences sector.

ContraFect Corporation, a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, announced the pricing of its underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $5.00 per share.

IMMUNOPRECISE ANTIBODIES LTD. a leader in full-service, therapeutic antibody discovery and development, announced financial results for the third quarter of its 2021 fiscal year ended January 31, 2020.

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced the pricing of an underwritten public offering of 16,000,000 shares of its common stock at a public offering price of $3.50 per share.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that it has changed the timing of its previously announced earnings conference call.

Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the appointment of Don Hardison to the Company’s strategic advisory board.

Monocent Inc., (Monocent) is pleased to announce the COFEPRIS authorization of their SARS-CoV2 Antigen Rapid test System for detection of COVID-19 infection. The Monocent antigen test is a lateral flow test that provides results in just 15-minutes, without the use of any laboratory equipment.

Versantis, a clinical-stage company developing novel therapies for orphan liver and pediatric diseases, announced positive results from a Phase 1b clinical trial of VS-01 in decompensated liver cirrhosis.

Throughout this pandemic, thousands of Canadians have had to continue working to provide essential services, such as in food production and packing plants, as well as in grocery stores, restaurants, and bars.